Sign In

Rob Bookstein

Principal Molecular Pathologist @ Adaptive Biotechnologies | California and Washington Medical Licenses

Rob Bookstein is a highly experienced Principal Molecular Pathologist at Adaptive Biotechnologies, overseeing the final report review and approval for the clonoSeq assay. With a strong background in biomedical science and pathology, he holds board certifications in Anatomic Pathology and Molecular Genetic Pathology. Rob has been a consultant for Illumina Ventures, focusing on genetic test development and interpretation for various applications in CLIA lab settings. He is dedicated to advancing cancer genetics research and applying NGS technologies to enhance patient diagnosis and treatment.

Highlights

Mar 8 · linkedin

Register to attend the 4th Annual Business of Personalized Medicine Summit on March 28 in South San Francisco — a one-of-a-kind, can't-miss event for startups and established companies alike!   This event will examine in depth the current financial-, regulatory-, policy-, R&D-, and technology-related complexities, trends, and opportunities impacting the marketplace and the future of health care. Top executives from across multiple stakeholder perspectives will explore some of the innovative partnering and collaboration already taking place throughout the industry, plus strategies for capitalizing on this challenging yet profitable market and solutions for continuing to advance the field.   This year’s keynote presenters include Nick Naclerio, PhD, Founder & Managing Partner of Illumina Ventures, as well as Drs. Lucian Iancovici and Aaron Nelson, General Partners at dRx Capital AG, a Novartis & Qualcomm joint investment company. Learn more and register today! http://bit.ly/1KpGiaO. https://lnkd.in/ggwtJWB

Aug 8 · linkedin

I finally scrolled to the very bottom of the list of "People I May Know" -- it is not infinite! So excited.

Rob Bookstein
Add to my network

Location

San Diego, California, United States